e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Translational studies of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease
A. van der Does (Leiden, Netherlands)
Source:
International Congress 2017 – Translational studies of lung disease
Session:
Translational studies of lung disease
Session type:
Thematic Poster
Number:
3913
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. van der Does (Leiden, Netherlands). Disturbed fatty acid metabolism in airway secretions of patients with Chronic Obstructive Pulmonary Disease. 3913
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002
Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009
Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Association of serum uric acid levels and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept